MiNK Therapeutics (INKT) Stock Chart & Stock Price History $14.58 +0.31 (+2.14%) As of 03:31 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MiNK Therapeutics Stock Price Performance The MiNK Therapeutics (INKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 93.82%, with a year-to-date return of 109.14%. In the past month, the stock has decreased 2.25%, reflecting recent market activity. As of the latest close, MiNK Therapeutics traded at $14.27 with a market cap of $64.50 million and volume of 28,693 shares. Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-0.51%1 Month Performance-2.25%3 Month Performance+98.03%Year-To-Date Performance+109.14%1 Year Performance+93.82% INKT Stock Chart for Tuesday, September, 16, 2025 INKT Chart by TradingView MiNK Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/15/2025$14.40$14.27-0.90%$14.51$14.0028,693 shs$64.50 million09/12/2025$14.65$14.40-1.71%$14.98$14.1037,016 shs$65.09 million09/11/2025$15.29$14.65-4.19%$15.56$14.6529,620 shs$66.26 million09/10/2025$15.36$15.29-0.46%$15.95$14.9762,488 shs$69.11 million09/09/2025$15.83$15.36-2.97%$16.01$14.9538,592 shs$69.43 million09/08/2025$14.80$15.83+6.96%$16.20$14.7969,441 shs$71.60 million09/05/2025$13.75$14.80+7.64%$15.26$13.4051,341 shs$66.94 million09/04/2025$14.07$13.75-2.27%$14.45$13.1152,130 shs$62.15 million09/03/2025$13.86$14.07+1.52%$14.94$13.8672,378 shs$63.60 million09/02/2025$14.24$13.86-2.67%$15.26$13.5437,632 shs$62.69 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/01/2025$14.24$14.24$15.12$14.1451,696 shs$64.37 million08/29/2025$14.82$14.24-3.91%$15.12$14.1451,696 shs$64.37 million08/28/2025$15.98$14.82-7.26%$16.30$14.7540,091 shs$66.99 million08/27/2025$15.15$15.98+5.48%$16.15$15.1543,763 shs$72.23 million08/26/2025$14.57$15.15+3.98%$15.48$14.4132,990 shs$68.48 million08/25/2025$14.90$14.57-2.21%$15.66$14.5717,341 shs$65.86 million08/22/2025$14.95$14.90-0.33%$15.64$14.7638,436 shs$67.35 million08/21/2025$14.47$14.95+3.32%$15.48$14.3529,575 shs$67.57 million08/20/2025$14.70$14.47-1.56%$15.24$14.2541,638 shs$57.68 million08/19/2025$14.62$14.70+0.55%$15.48$14.31100,442 shs$58.65 million08/18/2025$14.91$14.62-1.95%$15.00$13.9086,708 shs$58.33 million08/15/2025$15.32$14.91-2.68%$18.17$14.91188,966 shs$59.49 million Related Companies Cartesian Therapeutics Stock Chart Tonix Pharmaceuticals Stock Chart Jade Biosciences Stock Chart Allogene Therapeutics Stock Chart Atea Pharmaceuticals Stock Chart Lyell Immunopharma Stock Chart Adherex Technologies Stock Chart AC Immune Stock Chart Editas Medicine Stock Chart Prima BioMed Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INKT Stock Alerts